Close Menu

The headline previously incorrectly stated Roche's diagnostics business grew 10 percent year over year during the first nine months of the year. We regret the error.

NEW YORK – Roche said today that its diagnostics division revenues grew 4 percent year over year on a constant exchange rate in the first nine months of 2019, driven mainly by its immunodiagnostic testing portfolio. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.